[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-337122-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-337122-en":130},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","line-1-orf1p-is-a-promising-biomarker-in-cervical-intraepithelial-neoplasia-degree-assessment","LINE-1 ORF1p is a Promising Biomarker in Cervical Intraepithelial Neoplasia Degree Assessment","","Cervical intraepithelial neoplasia (CIN) includes a spectrum of preinvasive squamous lesions whose accurate classification is challenging because histomorphological differences can be subtle. The study evaluates ORF1p, a nucleic acid-binding protein derived from long interspersed nuclear element-1 (LINE-1), as a biomarker to improve CIN diagnosis. Analysis of 143 specimens shows widespread ORF1p expression in dysplastic and neoplastic cases, with increasing extent and intensity across CIN grades.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/line-1-orf1p-is-a-promising-biomarker-in-cervical-intraepithelial-neoplasia-degree-assessment/337122/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/line-1-orf1p-is-a-promising-biomarker-in-cervical-intraepithelial-neoplasia-degree-assessment/337122.png","ImageObject",300,407,{"name":42,"@type":43},"Clementine","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-11-01","2026-09-21",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",9,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"What problem does the study address in diagnosing cervical intraepithelial neoplasia (CIN)?","Question",{"text":63,"@type":64},"CIN diagnosis is difficult because histomorphological differences among categories can be subtle, making accurate classification challenging.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"Why is ORF1p considered a potential biomarker for CIN?",{"text":68,"@type":64},"ORF1p is a nucleic acid-binding protein derived from LINE-1, and the study investigates whether its expression patterns can support CIN detection and grading.",{"name":70,"@type":61,"acceptedAnswer":71},"How does ORF1p expression vary across CIN grades and normal tissue?",{"text":72,"@type":64},"ORF1p immunopositivity appears in the vast majority of dysplastic and neoplastic specimens, shows progressively increasing extent and intensity with advancing CIN grades, and is lacking in a majority of normal cervical specimens.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},337122,1790454905,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,111,115,119,122,126],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":107,"doc_module":4,"doc_module_name":25,"category_name":108,"show_sort_weight":109,"slug":110},7,"Healthcare",40,"healthcare",{"id":112,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":113,"slug":114},8,30,"research-report",{"id":55,"doc_module":4,"doc_module_name":25,"category_name":116,"show_sort_weight":117,"slug":118},"Religion & Spirituality",20,"religion-spirituality",{"id":117,"doc_module":4,"doc_module_name":25,"category_name":120,"show_sort_weight":117,"slug":121},"World Cup","world-cup",{"id":123,"doc_module":4,"doc_module_name":25,"category_name":124,"show_sort_weight":123,"slug":125},10,"Lifestyle","lifestyle",{"id":127,"doc_module":4,"doc_module_name":25,"category_name":128,"show_sort_weight":97,"slug":129},19,"General","general",{"code":4,"msg":82,"data":131},{"doc_id":79,"user_id":132,"nickname":42,"user_avatar":133,"doc_module":4,"category_id":112,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":55,"language":139,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":140,"faqs":141,"seo_title":142,"seo_description":12,"update_tm":143,"read_time":144,"preview_page_count":33,"preview_urls":145},1374391974564,"https://ap-avatar.wpscdn.com/avatar/14000253aa45c000a9e?x-image-process=image/resize,m_fixed,w_180,h_180&k=1779874745381141002","LINE-1 ORF1p is a Promising Biomarker in Cervical Intraepithelial Neoplasia Degree Assessment  \nRéka Karkas, MD,*† Khaldoon Sadiq Ahmed Abdullah, MSc,*† László Kaizer, MD, FRCPath,‡Ádám Ürmös, BA,§ May Raya, MSc,*† Lilla Tiszlavicz, MD,∥ Tibor Pankotai, PhD,‡§¶ István Nagy, PhD,\\#** Lajos Mátés, PhD,* and Farkas Sükösd, MD, PhD‡  \nAbstract: Cervical intraepithelial neoplasia (CIN) represents a spectrum of preinvasive squamous lesions within the cervical epithelium, whose identiﬁcation is a diagnostic challenge due to subtle histomorphological differences among its categories. This study explores ORF1p, a nucleic acid-binding protein derived from long interspersed nuclear element-1 (LINE-1), as a potential biomarker for enhancing CIN diagnosis. A comprehensive analysis of 143 cervical specimens, encompassing CIN I (n = 20), CIN II (n = 46), CIN III (n = 14), invasive cancer (n = 32), and nondysplastic cases (normal cervical epithelia (n = 24) and atrophy (n = 7) were con-  \nFrom the *Laboratory of Cancer Genome Research, Institute of Genetics, HUN-REN Biological Research Centre, Szeged, Hungary;†Doctoral School of Multidisciplinary Medical Sciences, University of Szeged, Albert Szent-Györgyi Medical School, Szeged, Hungary;‡Department of Pathology, Albert Szent-Györgyi Health Centre, University of Szeged, Szeged, Hungary; §Genome Integrity and DNA Repair Core Group, Hungarian Centre of Excellence for Molecular Medicine, Szeged, Hungary; ∥Department of Pediatrics and Pediatric Health Centre, Albert Szent-Györgyi Health Centre, University of Szeged, Szeged, Hungary; ¶Competence Centre of the Life Sciences Cluster of the Centre of Excellence for Interdisciplinary Research, Development and Innovation, University of Szeged, Hungary; \\#Seqomics Biotechnology Ltd, Mórahalom, Hungary; and **Sequencing Platform, Institute of Biochemistry, HUN-REN Biological Research Centre, Szeged, Hungary.  \nThe project was, in part, funded by the 2021-1 .1.4- GYORSÍTÓSÁV- 2022-00018 project of the National Research, Development and Innovation Fund, Hungary. R.K. was supported by the ÚNKP-23-3 New National Excellence Program of the Ministry for Culture and Innovation from the source of the National Research, Development, and Innovation Fund, Hungary.  \nR.K. and K. S.A.A. are joint ﬁrst authors.  \nThe authors declare no conﬂict of interest.  \nAddress correspondence to Farkas Sükösd, MD, PhD, Department of Pathology, University of Szeged, Állomás Street 1, Szeged H-6721, Hungary. E-mail: [sukosd.farkas@med.u-szeged.hu](sukosd.farkas@med.u-szeged.hu), and Lajos Mátés, PhD, Laboratory of Cancer Genome Research, Institute of Genetics, HUN-REN Biological Research Centre, Temesvári Blvd. 62, Szeged H-6726, [Hungary. E-mail: mates.lajos@brc.hu](Hungary. E-mail: mates.lajos@brc.hu).  \nSupplemental Digital Content is available for this article. Direct URL citations are provided in the HTML and PDF versions of this article on the journal’s website, [www.intjgynpathology.com](www.intjgynpathology.com).  \nCopyright © 2024 The Author(s) . Published by Wolters Kluwer Health, Inc. This is an open access article distributed under the terms of the Creative Commons Attribution-Non Commercial-No Derivatives License 4.0 (CCBY-NC-ND), where it is permissible to download and share the work provided it is properly cited. The work cannot be changed in any way or used commercially without permission from the journal.  \nDOI: 10.1097/PGP.0000000000001035  \n[22](22 | www.intjgynpathology.com)[ |](22 | www.intjgynpathology.com)[ www.intjgynpathology.com](22 | www.intjgynpathology.com)  \nducted. ORF1p, Ki67, and p16 expressions were evaluated using immunohistochemistry. ORF1p immunopositivity was detected in the vast majority [110/112 (98.2%)] of dysplastic and neoplastic (CIN and invasive cancer) specimens, whereas 19/24 (79.2%) of normal cervical specimens lacked ORF1p expression. The observed pattern of ORF1p expression showed a progressively increasing extent and intensity with ","cbCaioGaV5j4LxS6","https://ap.wps.com/l/cbCaioGaV5j4LxS6","pdf",789882,"English","# Background: cervical cancer and CIN\n## CIN classification and diagnostic challenge\n# Study focus: ORF1p/LINE-1 biomarker\n## Rationale for early diagnostic detection\n# Results: ORF1p expression across specimens\n## CIN I to cervical cancer patterns\n# Implications\n## ORF1p as an early indicator for cervical neoplasia","[{\"question\":\"What problem does the study address in diagnosing cervical intraepithelial neoplasia (CIN)?\",\"answer\":\"CIN diagnosis is difficult because histomorphological differences among categories can be subtle, making accurate classification challenging.\"},{\"question\":\"Why is ORF1p considered a potential biomarker for CIN?\",\"answer\":\"ORF1p is a nucleic acid-binding protein derived from LINE-1, and the study investigates whether its expression patterns can support CIN detection and grading.\"},{\"question\":\"How does ORF1p expression vary across CIN grades and normal tissue?\",\"answer\":\"ORF1p immunopositivity appears in the vast majority of dysplastic and neoplastic specimens, shows progressively increasing extent and intensity with advancing CIN grades, and is lacking in a majority of normal cervical specimens.\"}]","LINE-1 ORF1p is a Promising Biomarker in Cervical Intraepithelial Neoplasia Degree Assessment | PDF",1790017774,23,[146,150,154,158],{"page_no":22,"url":147,"width":148,"height":149},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/85dd48737d29e49ef218dde2fc0863cc.webp",983,1315,{"page_no":26,"url":151,"width":152,"height":153},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/93228fdaf825b54b1f4e32788e7fdffd.webp",982,1314,{"page_no":30,"url":155,"width":156,"height":157},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/c0c0cddbe634f01385b3c2612ea57a37.webp",981,1312,{"page_no":33,"url":159,"width":160,"height":161},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/aa0675fb2ff05df376d9ed50d6c9a2ff.webp",980,1311]